Splenectomy induced complete remission in a patient with multicentric Castleman's disease and autoimmune hemolytic anemia

Annals of Hematology

Volumn 78, Issue 4, 1999, Pages 193-196

  Lerza, Roberto ^b   Castello, G ^c   Truini, M ^a   Ballarino, P ^c   Tredici, S ^c   Cavallini, D ^c   Pannacciulli, I ^c  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c NONE

Author keywords

Castleman's disease; Immunohemolytic anemia; Splenectomy

Indexed keywords

CORTICOSTEROID; CYCLOPHOSPHAMIDE; DOXORUBICIN; METHYLPREDNISOLONE; PREDNISONE; VINCRISTINE;

ADULT; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; BLOOD CHEMISTRY; CASE REPORT; CLINICAL FEATURE; COOMBS TEST; DISEASE COURSE; HEMATOLOGICAL PARAMETERS; HEMOLYSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LYMPHOID TISSUE; MALE; PLASMAPHERESIS; PRIORITY JOURNAL; RADIOLOGY; REMISSION; SPLENECTOMY;

ANEMIA, HEMOLYTIC, AUTOIMMUNE; GIANT LYMPH NODE HYPERPLASIA; HUMANS; MALE; MIDDLE AGED; REMISSION INDUCTION; SPLENECTOMY;

EID: 0032955393     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002770050500     Document Type: Article

References (32)

1. Artusi T, Bonacorsi G, Saragoni A, et al (1982) Castleman's lymphadenopathy: twenty years of observation. II. Generalized form. Haematologica (Pavia) 67:124-142
2. Bartoli E, Massarelli G, Soggia G, et al (1980) Multicentric giant lymph node hyperplasia. A hyperimmune syndrome with a rapidly progressive course. Am J Clin Pathol 73:423-426
3. Bordeleau L, Christopher B, Markman S (1995) 2-Chlorodeoxyadenosine therapy for giant lymph node hyperplasia. Br J Haematol 91:668-670
4. Brandt SJ, Bodine DM, Dunbar CE, Nienhuis AW (1990) Dysregulated interleukin-6-expression produces a syndrome resembling Castleman's disease in mice. J Clin Invest 86:592
5. Chen KTK (1984) Multicentric Castleman's disease and Kaposi's sarcoma. Am J Surg Pathol 8:287-293
6. Combe C, Bouchet JL, Potaux L, Morel D, Deminiere C, Coindre JM, Aparicio M (1989) Castleman's disease and glomerular nephropathy. Nephrologie 10:163-166
7. Diebold J, Tulliez M, Bernadou A, et al (1980) Angiofollicular and plasmatic polyadenopathy: a pseudotumorous syndrome with dysimmunity. J Clin Pathol 33:1068-1076
8. Emilie D, Zou W, Fior R, Llorente L, Durandy A, Crevon MC, Maillot MC, Durand-Gasselin I, Raphael M, Peuchmaur M, Galamaud P (1997) Production and roles of IL-6, IL-10, and IL-13 in B-lymphocyte malignancies and in B-lymphocyte hyperactivity of HIV infection and autoimmunity. Methods 11:33-42
9. Featherstone T, Baylin AP, Ewen SWB, Brunt PW, Dawson AA (1990) Obscure anaemia and hepatic dysfunction in Castleman's disease. Gut 31:834
10. Foss HD, Araujo I, Demel G, Klotzbach H, Hummel M, Stein H (1997) Expression of vascular endothelial growth factor in lymphomas and Castleman's disease. J Pathol 183:44-50
11. Frizzera G (1985) Castleman's disease: more questions than answers. Hum Pathol 16:202-205
12. Frizzera G (1992) Atypical lymphoproliferative disorders. In: Knowles DM (ed) Neoplastic hematopathology. Williams & Wilkins, Baltimore, pp 466-486
13. Frizzera G, Peterson BA, Bayrd ED, Goldman A (1985) A systemic lymphoproliferative disorder with morphologic features of Castleman's disease: clinical findings and clinicopathologic correlations in 15 patients. J Clin Oncol 3:1202-1216
14. Gaba AR, Stein RS, Sweet DL, et al (1978) Multicentric giant lymph node hyperplasia. Am J Clin Pathol 69:86-90
15. Gohlke F, Marker-Hermann E, Kanzler S, Mitze M, Meyer zum Buschenfelde KH (1997) Autoimmune findings resembling connective tissue disease in a patient with Castleman's disease. Clin Rheumatol 16(1):87-92
16. Herrada J, Cabanillas F, Rice L, Manning J, Pugh W (1998) The clinical behaviour of localized and multicentric Castleman disease. Ann Intern Med 128:657-662
17. Higashi K, Matsuki Y, Hidaka T, Aida S, Suzuki K, Nakamura H (1997) Primary Sjögren's syndrome associated with hyaline-vascular type of Castleman's disease and autoimmune idiopathic thrombocytopenia. Scand J Rheumatol 26:482-484
18. Ikeda S, Chisuwa H, Kawasaki S, Ozawa J, Hoshii Y, Yokota T, Aoi T (1997) Systemic reactive amyloidosis associated with Castleman's disease: serial changes of the concentrations of acute phase serum amyloid A and interleukin 6 in serum. Clin Pathol 50:965-967
19. Kazes I, Deray G, Jacobs C (1995) Castelman disease and renal amyloidosis. Ann Intern Med 122:395-396
20. Keller AR, Hocholzer L, Castleman B (1972) Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer 29:670-683
21. Kessler E (1985) Multicentric giant lymph node hyperplasia: a report of seven cases. Cancer 56:2446-2451
22. Lui SL, Chan KW, Li FK, Cheng IK, Chan TM (1998) Castleman's disease and mesangial proliferative glomerulonephritis: the role of interleukin-6. Nephron 78:323-327
23. Menke DM, Tiemann M, Camoriano JK, Chang S, Madan A, Chow M, Habermann TM, Parwaresch R (1996) Diagnosis of Castleman's disease by identification of an immunophenotypically aberrant population of mantle zone B lymphocytes in paraffin-embedded lymph node biopsies. Haematopathology 105:268-276
24. Okuda K, Himeno Y, Toyama T, et al (1982) Gamma heavy chain disease and giant lymph node hyperplasia in a patient with impaired T cell function. Jpn J Med 21:109-114
25. Parravinci C, Corbellino M, Paulli M, Magrini U, Lazzarino M, Moore PS, Chang Y (1997) Expression of a virus-derived cytokine, KSHV vIL-6, in HIV-seronegative Castleman's disease. Am J Pathol 151:1517-1522
26. Peterson BA, Frizzera G (1993) Multicentric Castleman's disease. Semin Oncol 20:636-647
27. Phatak PD, Janas SJ, Sham LR, Yirinec B, Marder JK (1997) Disorders that resemble lymphomas. Am J Hematol 56:63-68
28. Summerfield GP, Taylor W, Bellingham AJ, et al (1983) Hyaline vascular variant of angiofollicular lymph node hyperplasia with systemic manifestations and response to corticosteroids. J Clin Pathol 36:1005-1011
29. Yabuhara A, Yana Gisawa M, Murata T, Kawai H, Komiyama A, Akabane T, Itoh M, Ishii E, Fujimoto J, Hata J (1989) Giant lymph node hyperplasia (Castleman's disease) with spontaneous production of high levels of B-cell differentiation factor activity. Cancer 63:260-265
30. Yoshizaki K, Matsuda T, Nishimoto N, Kuritani T, Taeho L, Aozasa K, Nakahata T, Kawai H, Tagoh H, Komori T, Kishiloto S, Hirano T, Kishimoto T (1989) Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease. Blood 74:1360-1367
31. Weisenburger DD, Nathwani BN, Winberg CD, Rappaport H (1985) Multicentric angiofollicular lymph node hyperplasia: a clinico-pathologic study of 16 cases. Hum Pathol 16:162-172
32. Winter SS, Howard TA, Ritchey AK, Keller FG, Ware RE (1996) Elevated levels of tumor necrosis factor-beta, gamma-interferon, and IL-6 mRNA in Castleman's disease. Med Pediatr Oncol 26:48-53